Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04865250 |
|---|---|
| Brief Title: | Predicting Response to Neoadjuvant ATEZOLIZUMAB Plus Carboplatin/Nab Paclitaxel in Resectable Non-squamous NSCLC (iReP) |
| First Submitted : | March 8, 2021 |
| First Submitted that Met QC Criteria : | April 25, 2021 |
| First Posted : | April 29, 2021 |
| Last Update Submitted that Met QC Criteria : | April 25, 2021 |
| Last Update Posted : | April 29, 2021 |